Schedule 13D ownership disclosure
Asterias Biotherapeutics, Inc.
Security class unavailable · CUSIP: 04624N107
Event date: 2018-03-28
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 38.8000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-18-004690
- Form type
- SC 13D
- Filer
- Lineage Cell Therapeutics, Inc.
- CIK
- CIK 876343
- Filed
- Apr 03, 2018
- Reporting period
- Mar 28, 2018
- Description
- Schedule 13D beneficial ownership